Technology assessment, coverage decisions, and conflict: The role of guidelines

American Journal of Managed Care

Volumn 4, Issue SPEC. ISS. SEPT., 1998, Pages

  Sheingold, Steven H ^a  

^a CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; DECISION MAKING; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE QUALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

CONFLICT OF INTEREST; DECISION MAKING, ORGANIZATIONAL; EVIDENCE-BASED MEDICINE; GUIDELINES; INSURANCE COVERAGE; MANAGED CARE PROGRAMS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 4243411952     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Ramsey SD, Luce BR, Deyo R, Franklin G. The limited state of technology assessment for medical devices: Facing the issues. Am J Man Care 1998;4:SP188-SP199.
2. Rettig RA. Health Care in Transition: Technology Assessment in the Private Sector. Santa Monica, CA: RAND; 1997.
3. Woolf S. Manual for Conducting Systematic Reviews. Washington, DC: Agency for Health Care Policy and Research; 1996.
4. Eddy DM. Investigational treatments: How strict should we be? JAMA 1997;278:179-185.
5. Grimes DA. Technology follies: The uncritical acceptance of medical innovation. JAMA 1993;269:3030-3033.
6. Tonelli MR, Benditt JO, Albert RK. Lessons from lung volume reduction surgery. Chest 1996;110:230-238.
7. United States General Accounting Office. Health Insurance Coverage of Autologous Bone Marrow Transplantation for Breast Cancer. Washington, DC: April 1996.
8. Grimes DA, Fleming TR, Demets DL. Surrogate endpoints in clinical trials: Are we being mislead? Ann Intern Med 1996;125:605-613.
9. Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in Wonderland of breast-cancer screening. N Engl J Med 1996;336:1180-1183.
10. Kiscaden S. Legislative Mandates and Consumer Information in Healthcare Technology Choices Under Managed Care: Communicating Directly with Patients and Their Clinicians. Plymouth Meeting, PA: ECRI; 1997.
11. Department of Health and Human Services. Report to Congress, Lung Volume Reduction Surgery and Medicare Coverage Policy: Implications of Recently Published Evidence. Baltimore, MD: June 1998.
12. Push is on to widen access to costly lung surgery. Boston Globe. April 29, 1998:A4.
13. Deyo RA, Psaty BM, Simon G, et al. The messenger under attack - intimidation of researchers by special-interest groups. N Engl J Med 1997;336:1176-1179.
14. Eisenberg JM. Statement before the Ways and Means Subcommittee on Health; April 17, 1997; Washington, DC.
15. Physician Payment Review Commission Annual Report. Washington, DC; 1992.
16. Task Force on Principles of Economic Analysis of Health Care Technology. Economic analysis of health care technology: A report on principles. Ann Intern Med 1995; 122:61-70.
17. Vladeck B. Statement before the Ways and Means Subcommittee on Health; April 17, 1997; Washington, DC.
18. Agency for Health Care Policy and Research. Magnetic Resonance Angiography: Vascular and Flow Imaging. AHCPR Pub. No. 95-0004. Rockville, MD; October 1994.